U.S. Optical Coherence Tomography (OCT) Market Size, Share, Trends, & Industry Analysis Report By Technology, By Type (Ophthalmology, Cardiovascular, Oncology, Dermatology, Other Applications), By Application – Market Forecast, 2025–2034
Description
The U.S. Optical coherence tomography market size is expected to reach USD 1,767.64 million by 2034, according to a new study by Polaris Market Research. The report “U.S. Optical Coherence Tomography (OCT) Market Share, Size, Trends, Industry Analysis Report: By Technology, By Type (Ophthalmology, Cardiovascular, Oncology, Dermatology, Other Applications), By Application; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Optical coherence tomography (OCT) can be defined as an advanced imaging modality that enables clinicians to capture cross-sectional, high-resolution images of biological tissues in real time. The U.S. OCT market is driven by the integration of artificial intelligence (AI) and machine learning into diagnostic imaging workflows. AI-driven OCT systems enable faster and more accurate detection of subtle pathological changes that might otherwise be missed by enhancing image interpretation. This improves diagnostic confidence while also streamlining clinical decision-making, reflecting the healthcare industry’s growing shift toward precision medicine and data-driven tools. The alignment of AI with OCT technology is accelerating innovation and expanding its clinical utility across diverse applications.
The continuous advancement of portable and user-friendly OCT devices further drives the U.S. OCT market. The development of compact, handheld, and easy-to-operate systems is making OCT more accessible in a variety of care settings, ranging from specialty clinics to point-of-care diagnostics. These innovations aim to meet the growing demand for convenience and efficiency in medical imaging, particularly in environments where rapid assessments are crucial. Portable OCT solutions are broadening adoption among healthcare providers while maintaining high imaging quality by reducing the dependency on large-scale infrastructure. This trend highlights the ongoing evolution of OCT technology toward greater adaptability and patient-centric care.
U.S. Optical Coherence Tomography (OCT) Market Report Highlights
In terms of technology, the time domain optical coherence tomography held largesr revenue share in 2024, driven by its entrenched installed base and proven reliability in standard ophthalmic diagnostic protocols.
Based on type, the doppler OCT segment is projected for the fastest growth, fueled by its unique value in providing simultaneous structural and functional blood flow imaging.
In terms of application, ophthalmology remains the dominant application segment, owing to the high volume of retinal disease management and OCT's standard-of-care status in the field.
A few global key market players include Abbott Laboratories, Agfa Healthcare, Carl Zeiss Meditec AG, Heidelberg Engineering GmbH, Koninklijke Philips, Michelson Diagnostics, Novacam Technologies Inc., OPTOPOL Technology S.A., Thorlabs Inc., and Topcon Medical Systems Inc.
Polaris Market Research has segmented the market report on the basis of technology, type, application:
By Technology Outlook (Revenue, USD Million, 2020–2034)
Time Domain Optical Coherence Tomography (TDOCT)
Frequency Domain Optical Coherence Tomography (FD-OCT)
Spatially Encoded Frequency Domain Optical Coherence Tomography
Fourier Domain Optical Coherence Tomography (FDOCT)
Spectral Domain Optical Coherence Tomography (SDOCT)
By Type Outlook (Revenue, USD Million, 2020–2034)
Catheter based OCT devices
Doppler OCT devices
Handheld OCT devices
Tabletop OCT devices
By Application Outlook (Revenue, USD Million, 2020–2034)
Ophthalmology
Cardiovascular
Oncology
Dermatology
Other Applications
Optical coherence tomography (OCT) can be defined as an advanced imaging modality that enables clinicians to capture cross-sectional, high-resolution images of biological tissues in real time. The U.S. OCT market is driven by the integration of artificial intelligence (AI) and machine learning into diagnostic imaging workflows. AI-driven OCT systems enable faster and more accurate detection of subtle pathological changes that might otherwise be missed by enhancing image interpretation. This improves diagnostic confidence while also streamlining clinical decision-making, reflecting the healthcare industry’s growing shift toward precision medicine and data-driven tools. The alignment of AI with OCT technology is accelerating innovation and expanding its clinical utility across diverse applications.
The continuous advancement of portable and user-friendly OCT devices further drives the U.S. OCT market. The development of compact, handheld, and easy-to-operate systems is making OCT more accessible in a variety of care settings, ranging from specialty clinics to point-of-care diagnostics. These innovations aim to meet the growing demand for convenience and efficiency in medical imaging, particularly in environments where rapid assessments are crucial. Portable OCT solutions are broadening adoption among healthcare providers while maintaining high imaging quality by reducing the dependency on large-scale infrastructure. This trend highlights the ongoing evolution of OCT technology toward greater adaptability and patient-centric care.
U.S. Optical Coherence Tomography (OCT) Market Report Highlights
In terms of technology, the time domain optical coherence tomography held largesr revenue share in 2024, driven by its entrenched installed base and proven reliability in standard ophthalmic diagnostic protocols.
Based on type, the doppler OCT segment is projected for the fastest growth, fueled by its unique value in providing simultaneous structural and functional blood flow imaging.
In terms of application, ophthalmology remains the dominant application segment, owing to the high volume of retinal disease management and OCT's standard-of-care status in the field.
A few global key market players include Abbott Laboratories, Agfa Healthcare, Carl Zeiss Meditec AG, Heidelberg Engineering GmbH, Koninklijke Philips, Michelson Diagnostics, Novacam Technologies Inc., OPTOPOL Technology S.A., Thorlabs Inc., and Topcon Medical Systems Inc.
Polaris Market Research has segmented the market report on the basis of technology, type, application:
By Technology Outlook (Revenue, USD Million, 2020–2034)
Time Domain Optical Coherence Tomography (TDOCT)
Frequency Domain Optical Coherence Tomography (FD-OCT)
Spatially Encoded Frequency Domain Optical Coherence Tomography
Fourier Domain Optical Coherence Tomography (FDOCT)
Spectral Domain Optical Coherence Tomography (SDOCT)
By Type Outlook (Revenue, USD Million, 2020–2034)
Catheter based OCT devices
Doppler OCT devices
Handheld OCT devices
Tabletop OCT devices
By Application Outlook (Revenue, USD Million, 2020–2034)
Ophthalmology
Cardiovascular
Oncology
Dermatology
Other Applications
Table of Contents
125 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. U.S. Optical Coherence Tomography (OCT) Market Insights
- 4.1. U.S. Optical Coherence Tomography (OCT) Market – Market Snapshot
- 4.2. U.S. Optical Coherence Tomography (OCT) Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Labour Costs in Agriculture
- 4.2.1.2. Rising Global Food Demand
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Initial Investment Costs
- 4.2.3. Public opinion and privacy legal precedents
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. U.S. Optical Coherence Tomography (OCT) Market Trends
- 4.6. Value Chain Analysis
- 5. U.S. Optical Coherence Tomography (OCT) Market, By Technology
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. U.S. Optical Coherence Tomography (OCT) Market, By Technology, 2020–2034 (USD Million)
- 5.3. Time Domain Optical Coherence Tomography (TDOCT)
- 5.3.1. U.S. Optical Coherence Tomography (OCT) Market, by Time Domain Optical Coherence Tomography (TDOCT), 2020–2034 (USD Million)
- 5.4. Frequency Domain Optical Coherence Tomography (FD-OCT)
- 5.4.1. U.S. Optical Coherence Tomography (OCT) Market, by Frequency Domain Optical Coherence Tomography (FD-OCT), 2020–2034 (USD Million)
- 5.5. Spatially Encoded Frequency Domain Optical Coherence Tomography
- 5.5.1. U.S. Optical Coherence Tomography (OCT) Market, by Spatially Encoded Frequency Domain Optical Coherence Tomography, 2020–2034 (USD Million)
- 5.5.2. Fourier Domain Optical Coherence Tomography (FDOCT)
- 5.5.2.1. U.S. Optical Coherence Tomography (OCT) Market, by Fourier Domain Optical Coherence Tomography (FDOCT), 2020–2034 (USD Million)
- 5.5.3. Spectral Domain Optical Coherence Tomography (SDOCT)
- 5.5.3.1. U.S. Optical Coherence Tomography (OCT) Market, by Spectral Domain Optical Coherence Tomography (SDOCT), 2020–2034 (USD Million)
- 6. U.S. Optical Coherence Tomography (OCT) Market, By Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. U.S. Optical Coherence Tomography (OCT) Market, By Type, 2020–2034 (USD Million)
- 6.3. Catheter based OCT devices
- 6.3.1. U.S. Optical Coherence Tomography (OCT) Market, by Catheter based OCT devices, 2020–2034 (USD Million)
- 6.4. Doppler OCT devices
- 6.4.1. U.S. Optical Coherence Tomography (OCT) Market, by Doppler OCT devices, 2020–2034 (USD Million)
- 6.5. Handheld OCT devices
- 6.5.1. U.S. Optical Coherence Tomography (OCT) Market, by Handheld OCT devices, 2020–2034 (USD Million)
- 6.6. Tabletop OCT devices
- 6.6.1. U.S. Optical Coherence Tomography (OCT) Market, by Tabletop OCT devices, 2020–2034 (USD Million)
- 7. U.S. Optical Coherence Tomography (OCT) Market, By End Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. U.S. Optical Coherence Tomography (OCT) Market, By End Use, 2020–2034 (USD Million)
- 7.3. Ophthalmology
- 7.3.1. U.S. Optical Coherence Tomography (OCT) Market, by Ophthalmology, 2020–2034 (USD Million)
- 7.4. Cardiovascular
- 7.4.1. U.S. Optical Coherence Tomography (OCT) Market, by Cardiovascular, 2020–2034 (USD Million)
- 7.5. Oncology
- 7.5.1. U.S. Optical Coherence Tomography (OCT) Market, by Oncology, 2020–2034 (USD Million)
- 7.6. Dermatology
- 7.6.1. U.S. Optical Coherence Tomography (OCT) Market, by Dermatology, 2020–2034 (USD Million)
- 7.7. Other Applications
- 7.7.1. U.S. Optical Coherence Tomography (OCT) Market, by Other Applications, 2020–2034 (USD Million)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. BaySpec, Inc.
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. KUB Technologies Inc.
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Leica Microsystems
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Lumedica, Inc.
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Nanoscope Instruments, Inc.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Nidek USA
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Sensors Unlimited, Inc.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Thorlabs, Inc.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Visionix
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.